In the dental implants procedures, the placement of the implant can be limited by deficiency of the alveolar socket caused by resorption of bone after extraction of a tooth which is followed by a significant dimensional changes in the alveolar crest. This leads to a reduction of the height and width of the alveolar socket and to a reduced amount of available residual bone for implant placement. For this reason, alveolar socket preservation is a key procedure of contemporary clinical dentistry.
The Rigenera Technology consists of a minimally invasive procedure. The entire procedure occurs in one surgical time and lasts for about 30 minutes. The whole procedure can be managed in a private practice by a physician, who has received a dedicated training.
In an autologous, homologous and minimally invasive manner where the patient is both donor and acceptor.
The micrografts are obtained starting from small fragments of tissue harvested using a dermal punch, and then mechanically disaggregated with the Rigeneracons medical device. The processed tissue can be then used as a micrograft.
Rigenera technology results extremely functional also in the Oral surgery field, in fact has been reported that autologous micro-grafts derived from periosteum are able to reduce the bone resorption of the alveolar crest suggesting that this can be an optimal approach of alveolar socket preservation.
Over time, the number of scientific contributions about the applications of the Rigenera Technology to the field of Oral surgery has grown. Scientific papers represent a tangible testimony of the practical applications of Rigenera.
You can find out more about our: